Aetna considers robotic-assisted rehabilitation of the upper limb and lower limb experimental and investigational for stroke and for all other indications (e.g., incomplete spinal cord injury, neuromuscular diseases such as cerebral palsy and multiple sclerosis, and Parkinson disease; not an all-inclusive list) because of insufficient evidence of its effectiveness.
See also CPB 0665 Constraint-Induced Therapy.Background
According to the American Heart Association, stroke is a major cause of long-term disability in the United States. Over 50 % of patients with upper limb paresis resulting from stroke face long-term impaired arm function and ensuing disability in daily life (Verbunt et al, 2008). Reducing the degree of permanent disability is the goal of post-stroke neurorehabilitation programs. Therapy that incorporates active assistance of motor tasks is a common technique in upper extremity rehabilitation after stroke. It has been proposed that this type of therapy may be facilitated by robotic devices. Exoskeletal or "wearable" robots are intended to provide therapeutic exercise or to function as powered orthoses to help compensate for chronic weakness.
In a randomized controlled pilot study, Kahn and associates (2006a) investigated the effects of robotically administered active-assistive exercise compared to free reaching voluntary exercise in improving arm movement ability after chronic stroke. A total of 19 individuals at least 1 year post-stroke were randomized into 1 of 2 groups. One group performed 24 sessions of active-assistive reaching exercise with a simple robotic device, while a 2nd group performed a task-matched amount of un-assisted reaching. The main outcome measures were range and speed of supported arm movement, range, straightness and smoothness of un-supported reaching, and the Rancho Los Amigos Functional Test of Upper Extremity Function. There were significant improvements with training for range of motion (ROM) and velocity of supported reaching, straightness of un-supported reaching, and functional movement ability. These improvements were not significantly different between the 2 groups. The group that performed un-assisted reaching exercise improved the smoothness of their reaching movements more than the robot-assisted group. The authors concluded that improvements with both forms of exercise confirmed that repeated, task-related voluntary activation of the damaged motor system is a key stimulus to motor recovery following stroke and that robotically assisting in reaching improved arm movement ability, although it did not provide any detectable, additional value beyond the movement practice that occurred concurrently with it. The authors stated that the inability to detect any additional value of robot-assisted reaching may have been due to the limited sample size of the study and the specific diagnoses of the participants, or the inclusion of only individuals with chronic stroke.
The Myomo e100 robotic arm brace (Myomo, Inc., Boston, MA) is an electromechanically powered elbow brace that received 510(k) marketing clearance in April 2007. It is intended to facilitate arm movement and maintain or increase ROM of the arm for stroke patients undergoing rehabilitation. The device contains a computerized system that detects changes in the patient's resting muscle potential through EMG sensors placed on the skin. The computerized system translates these electrical signals into the desired motion and then responds in real time with a power boost from the device's motorized elbow brace to assist the desired motion. The device would be included as part of prescribed physical therapy to enable stroke patients to exercise that would otherwise be unable to independently do so. The amount of assistance provided by the Myomo e100 can vary as the patient fatigues or gains strength. The objective of the EMG-triggered action is to engage and reinforce both neurological and motor pathways to help the patient relearn how to move affected muscles. The Myomo e100 can be configured for either the left or right arm, and to detect electrical activity from either the biceps or triceps. Unlike some earlier robotic therapy devices that were stationary, the Myomo e100 is a wearable device. It is designed to act as an aid for exercise training and may be developed for use as an actively powered orthosis to assist with difficult motions.
Stein et al (2007) reported the results of the Myomo e100 device on 6 stroke patients with severe chronic hemiparesis. Each patient used the device for a total of 18 hrs of exercise therapy (2 to 3 hrs per week) for a period of 6 weeks. The average age of the patients was 53 years, and the average time since their stroke was 3.67 years. A 7th patient did not have sufficient EMG signals to control the device. Patients performed exercises including a defined set of functional tasks (moving blocks or turning light switches on or off) with the robotic brace. They were able to control the motorized brace to assist in these motions. Assessment by both the Fugl-Meyer scale and the modified Ashworth scale (a measure of muscle spasticity) showed improvement in upper extremity motor function. The authors concluded that the EMG-controlled powered elbow orthoses show promise as a new modality for assisted exercise training after stroke. They stated that further studies are needed to confirm these preliminary results.
Chang et al (2007) analyzed the results of a training program (40 mins/session, 3 sessions/week for 8 weeks) consisting of 10 mins of conventional rehabilitation and 30 mins of robot-aided, bilateral force-induced, isokinetic arm movement training to improve paretic upper-limb motor function. The post-test and retention test in arm motor function significantly improved in terms of grip (p = 0.009), push (p = 0.001), and pull (p = 0.001) strengths, and Fugl-Meyer Assessment upper-limb scale (p < 0.001). Reaching kinematics significantly improved in terms of movement time (p = 0.015), peak velocity (p = 0.035), percentage of time to peak velocity (p = 0.004), and normalized jerk score (p = 0.008). Improvement in reaching ability was not sustained in the retention test. The authors concluded that these preliminary results showed that conventional rehabilitation combined with robot-aided, bilateral force-induced, isokinetic arm training might enhance the recovery of strength and motor control ability in the paretic upper limb of patients with chronic stroke.
Kwakkel et al (2008) conducted a systematic review on the effects of robot-assisted therapy on motor and functional recovery of the upper limb in stroke patients. Randomized clinical trials published up to October 2006 that satisfied the following selection criteria were included: (i) patients diagnosed with cerebral vascular accident, (ii) effects of robot-assisted therapy for the upper limb, and (iii) outcomes reported in terms of motor and/or functional recovery of the upper paretic limb. For each outcome measure, the estimated effect size (ES) and the summary effect size (SES) expressed in standard deviation units (SDU) were calculated for motor recovery and functional ability (activities of daily living [ADLs]) using fixed and random effect models. Ten studies, involving 218 patients, were included in the synthesis. Their methodological quality ranged from 4 to 8 on a (maximum) 10-point scale. Meta-analysis showed a non-significant heterogeneous SES in terms of upper limb motor recovery. Sensitivity analysis of studies involving only shoulder-elbow robotics subsequently demonstrated a significant homogeneous SES for motor recovery of the upper paretic limb. No significant SES was observed for functional ability (ADL). The authors reported that as a result of marked heterogeneity in studies between distal and proximal arm robotics, no overall significant effect in favor of robot-assisted therapy was found. However, subsequent sensitivity analysis showed a significant improvement in upper limb motor function after stroke for upper arm robotics. No significant improvement was found in ADL function. However, the administered ADL scales in the reviewed studies failed to adequately reflect recovery of the paretic upper limb, whereas valid instruments that measured outcome of dexterity of the paretic arm and hand were mostly absent in the selected studies. The authors concluded that future research into the effects of robot-assisted therapy should therefore distinguish between upper and lower robotics arm training and concentrate on kinematical analysis to differentiate between genuine upper limb motor recovery and functional recovery due to compensation strategies by proximal control of the trunk and upper limb. An evaluation of this systematic evidence review by the Center for Reviews and Dissemination (2009) stated that the conclusions of this systematic review "should be treated with caution in view of the uncertain clinical and statistical significance of the results and the small sizes of the included trials" and that the authors suggestions for further research seemed appropriate.
A Cochrane systematic review (Mehrholz et al, 2008) evaluated the evidence of the effectiveness of electromechanical and robot-assisted training for improving arm function after stroke. Randomized controlled trials comparing electromechanical and robot-assisted arm training for recovery of arm function with other rehabilitation interventions or no treatment for patients after stroke were selected for review. Eleven trials (328 participants) met the inclusion criteria. The authors reported that electromechanical and robot-assisted arm training did not improve ADLs but arm motor function and arm motor strength improved. These results must be interpreted with caution, however, because there were variations between the trials in the duration, amount of training and type of treatment, and in the patient characteristics. The authors concluded, "It is, therefore, not clear if such devices should be applied in routine rehabilitation, or when and how often they should be used." A Cochrane systematic evidence review also found that there is insufficient evidence for the use of robotic-assisted gait training after spinal cord injury (SCI) (Mehrholz et al, 2008). Two review authors independently selected trials for inclusion, assessed trial quality and extracted the data. The primary outcomes were the speed of walking and walking capacity at follow-up. A total of 4 randomized controlled trials (RCTs) involving 222 patients were included in this review. Overall, the results were inconclusive. There was no statistically significant effect of locomotor training on walking function after SCI comparing body-weight supported treadmill training with or without functional electrical stimulation or robotic-assisted locomotor training. The authors concluded that there is insufficient evidence from RCTs to conclude that any one locomotor training strategy improves walking function more than another for people with SCI. Research in the form of large RCTs is needed to address specific questions about the type of locomotor training which might be most effective in improving walking function of people with SCI.
In a RCT, Hornby et al (2008) examined the effects of robotic-assisted versus therapist-assisted locomotor training (LT). Both groups received 12 LT sessions for 30 mins at similar speeds, with guided symmetrical locomotor assistance using a robotic orthosis versus manual facilitation from a single therapist using an assist-as-needed paradigm. Outcome measures included gait speed and symmetry, and clinical measures of activity and participation. Greater improvements in speed and single limb stance time on the impaired leg were observed in subjects who received therapist-assisted LT, with larger speed improvements in those with less severe gait deficits. Perceived rating of the effects of physical limitations on quality of life improved only in subjects with severe gait deficits who received therapist-assisted LT. The authors concluded that therapist-assisted LT facilitates greater improvements in walking ability in ambulatory stroke survivors as compared to a similar dosage of robotic-assisted LT.
In a multi-center, randomized clinical trial, Hilder and colleagues (2009) compared the effectiveness of robotic-assisted gait training with the Lokomat to conventional gait training in individuals with subacute stroke. A total of 63 participants less than 6 months post-stroke with an initial walking speed between 0.1 to 0.6 m/s completed the study. All participants received 24 1-hr sessions of either Lokomat or conventional gait training. Outcome measures were evaluated prior to training, after 12 and 24 sessions, and at a 3-month follow-up examination. Self-selected overground walking speed and distance walked in 6 mins were the primary outcome measures, whereas secondary outcome measures included balance, mobility and function, cadence and symmetry, level of disability, and quality of life measures. Participants who received conventional gait training experienced significantly greater gains in walking speed (p = 0.002) and distance (p = 0.03) than those trained on the Lokomat. These differences were maintained at the 3-month follow-up evaluation. Secondary measures were not different between the 2 groups, although a 2-fold greater improvement in cadence was observed in the conventional versus Lokomat group. The authors concluded that for subacute stroke patients with moderate-to-severe gait impairments, the diversity of conventional gait training interventions appears to be more effective than robotic-assisted gait training for facilitating returns in walking ability.
In a randomized clinical trial, Lewek et al (2009) determined whether LT with physical assistance as needed was superior to guided, symmetrical, robotic-assisted LT for improving kinematic coordination during walking post-stroke. A total of 19 people with chronic stroke (greater than 6 months' duration) participating in a RCT comparing therapist-assisted versus robotic-assisted LT were recruited. Prior to and following 4 weeks of LT, gait analysis was performed at each participant's self-selected speed during overground walking. Kinematic coordination was defined as the consistency of intra-limb hip and knee angular trajectories over repeated gait cycles and was compared before and after treatment for each group. Locomotor training with therapist assistance resulted in significant improvements in the consistency of intra-limb movements of the impaired limb. Providing consistent kinematic assistance during robotic-assisted LT did not result in improvements in intra-limb consistency. Only minimal changes in discrete kinematics were observed in either group. The authors concluded that coordination of intra-limb kinematics appears to improve in response to LT with therapist assistance as needed. Fixed assistance, as provided by this form of robotic guidance during LT, however, did not alter intra-limb coordination.
In a non-blinded prospective RCT, Schwartz and co-workers (2009) assessed the effectiveness of early and prolonged LT with the use of a robotic-assisted gait training (RAGT) device (Lokomat; Hocoma Inc., Zurich, Switzerland) on the functional outcomes of patients after subacute stroke. A total of 67 patients in the first 3 months after subacute stroke were randomized into 2 groups as follows: (i) 37 patients were treated with RAGT, and (ii) 30 were treated with regular physiotherapy. Inclusion criteria were first stroke, independent ambulation before the stroke, and neurological severity between 6 and 20 according to the National Institutes of Health Stroke Scale (NIHSS). RAGT treatment was administered 3 times a week for 30 mins, combined with regular physiotherapy for 6 weeks. Control patients received the equivalent additional time of regular physiotherapy. The primary outcome was the ability to walk independently, as assessed by use of the functional ambulatory capacity scale. The secondary outcomes included the neurological status according to the NIHSS; functional motor assessment (determined by use of the stroke activity scale); and gait parameters, including gait velocity, endurance, and number of climbed stairs. In the intention-to-treat analysis, subjects in the RAGT group exhibited greater gains than the control group in their ability to walk independently, as expressed by a greater functional ambulatory capacity score (p < 0.01), and in their neurological status according to NIHSS (p < 0.01). Among those who achieved independent walking, non-significant differences between groups were noted according to secondary outcome measures of gait parameters except from step climbing. The authors concluded that this controlled study showed, at the end of a 6-week trial, that LT with the use of RAGT combined with regular physiotherapy produced promising effects on functional and motor outcomes in patients after subacute stroke as compared with regular physiotherapy alone.
In a preliminary study, Kutner et al (2010) examined changes in patient-reported, health-related quality of life associated with robotic-assisted therapy combined with reduced therapist-supervised training in patients with subacute stroke. A total of 17 individuals who were 3 to 9 months post-stroke participated in this study. Sixty hrs of therapist-supervised repetitive task practice (RTP) was compared with 30 hrs of RTP combined with 30 hrs of robotic-assisted therapy. Participants completed the Stroke Impact Scale (SIS) at baseline, immediately post-intervention, and 2 months post-intervention. Change in SIS score domains was assessed in a mixed model analysis. The combined therapy group had a greater increase in rating of mood from pre-intervention to post-intervention, and the RTP-only group had a greater increase in rating of social participation from pre-intervention to follow-up. Both groups had statistically significant improvement in activities of daily living and instrumental activities of daily living scores from pre-intervention to post-intervention. Both groups reported significant improvement in hand function post-intervention and at follow-up, and the magnitude of these changes suggested clinical significance. The combined therapy group had significant improvements in stroke recovery rating post-intervention and at follow-up, which appeared clinically significant; this also was true for stroke recovery rating from pre-intervention to follow-up in the RTP-only group. The major limitation of this study was that outcome of 30 hrs of RTP in the absence of robotic-assisted therapy remain unknown. The authors concluded that robotic-assisted therapy may be an effective alternative or adjunct to the delivery of intensive task practice interventions to enhance hand function recovery in patients with stroke. These prelininary findings need to be validated by further investigation.
In a case-series study, Meyer-Heim and colleagues (2009) measured functional gait improvements of robotic-assisted locomotion training in children with cerebral palsy (CP). A total of 22 children (mean age of 8.6 years, range of 4.6 to 11.7) with CP and a gross motor function classification system level II to IV were enrolled in this study. Subjects received 3 to 5 sessions of 45 to 60 mins/week during a 3- to 5-week period of driven gait orthosis training. Main outcome measures included 10-meter walk test (10MWT), 6-min walk test (6MinWT), gross motor function measure (GMFM-66) dimension D (standing) and dimension E (walking), and functional ambulation categories (FAC). The mean (SD) maximum gait speed (0.78 (0.57) to 0.91 (0.61) m/s; p < 0.01) as well as the mean (SD) dimension D of the GMFM-66 (40.3 % (31.3 %) to 46.6 % (28.7 %); p < 0.05) improved significantly after the intervention period. The mean (SD) 6MinWT (176.3 (141.8) to 199.5 (157.7) m), the mean FAC (2.6 (1.7) to 3.0 (1.6)) and the mean (SD) dimension E of the GMFM-66 (29.5 % (30.3 %) to 31.6 % (29.2 %)) also showed an increase, but did not reach a statistically significant level. These authors concluded that these findings suggested that children with CP benefit from robotic-assisted gait training in improving functional gait parameters. These findings need to be validated by well-deisgned studies.
In a RCT, Druzbicki et al (2013) evaluated gait in children with spastic diplegic CP (n = 52) rehabilitated with the use of Lokomat active orthosis. Temporo-spatial parameters of gait and selected kinematic parameters were assessed. Childrem from the study group used active orthosis in addition to following a program of individual exercises. Children in the control group participated only in individual exercises. The difference between the initial and control examinations was statistically insignificant. After the program was finished, there was a slight improvement in walking speed in both groups. Improvement in the mean walking speed was not significantly different between the groups (p = 0.5905). Range of motion decreased slightly in both groups, and the difference between mean amounts of change was not significant (p = 0.8676). There was significant improvement in maximal range of flexion in the hip joint (p = 0.0065) in the study. It was shown that with a decrease in the mean value of adduction in hip joint, the mean walking speed increased (r = -0.53, p = 0.0011). The authors concluded that this study had several limitations, thus, these results should be regarded as preliminary. Moreover, they stated that further research consistent with the above indications is needed to investigate the impact of this new treatment option in patients with CP.
In a systematic review, Hayward et al (2010) examined the effect of interventions that promote upper limb (UL) recovery in stroke survivors with severe paresis. A systematic search of the scientific literature from January 1970 to March 2009 was conducted using CINAHL, Cochrane, PEDro, Pubmed and Web of Science. Keywords used included stroke, severe, hemiplegia, upper limb, task-oriented, robot, non-robot and electrical stimulation. Methodological quality of the studies was assessed using the PEDro rating scale. Studies were grouped into 1 of 3 intervention categories: (i) robotic therapy, (ii) electrical stimulation or (iii) "other" therapy. A total of 17 RCTs met the inclusion criteria. A "best evidence synthesis" indicated strong evidence that robotic therapy provides a large beneficial effect and limited evidence that electrical stimulation and "other" interventions provide a large beneficial effect on function. There is no evidence that these interventions influence use of the arm in everyday tasks. The authors concluded that there are a number of newly developed interventions that enable stroke survivors with severe paresis to actively participate in task-oriented practice to promote UL recovery. While these interventions offer some promise for stroke survivors with severe paresis, ultimately, the effectiveness of these interventions will be based on whether they lead to restoration of function to the point at which the stroke survivor can practice everyday tasks.
Swinnen et al (2010) evaluated the quality of current evidence as to the effectiveness of RAGT in patients with SCI, focusing on walking ability and performance. A search was conducted in MEDLINE, Web of Knowledge, Cochrane Library, Physiotherapy Evidence Database (PEDro) and Digital Academic Repositories (DAREnet) (1990 to 2009). Key words included "spinal cord injury", "(robot-assisted) gait rehabilitation" and "driven gait orthosis". Articles were included when complete and incomplete adult spinal cord injured patients participated in RAGT intervention studies. The methodological quality was rated independently by 2 researchers using "van Tulder criteria list" and "evaluation of quality of an intervention study". Descriptive analyses were performed using the Population Intervention Comparison Outcome (PICO) method. Two RCTs (mean quality score: 11.5/19) and 4 pre-experimental trials (mean quality score: 24.25 (standard deviation; SD 0.28/48) involving 43 patients with incomplete, acute or chronic lesions between C3 and L1 were analysed. Five studies used the Lokomat and 1 used the LokoHelp. Although some improvements were reported related to body functions and activities, there is insufficient evidence to draw firm conclusions, due to small samples sizes, methodological flaws and heterogeneity of training procedures. The authors concluded that there is currently no evidence that RAGT improves walking function more than other locomotor training strategies. They stated that well-designed RCTs are needed.
The Veterans Health Administration and the Department of Defense's clinical practice guideline for the management of stroke rehabilitation (2010) stated that "[t]here is no sufficient evidence supporting use of robotic devices during gait training in patients post stroke" (regarding gait training strategies for lower extremities).
In a pilot study, Zariffa et al (2012) examined the use of an upper limb robotic rehabilitation device (Armeo Spring, Hocoma AG, Switzerland) in a subacute cervical SCI population. A total of 12 subjects (motor level C4 to C6, ASIA Impairment Scale A-D) completed the training, which consisted of 16.1 +/- 4.6 sessions over 5.2 +/- 1.4 weeks. Two types of outcomes were recorded: (i) feasibility of incorporating the device into an inpatient rehabilitation program (compliance with training schedule, reduction in therapist time required and subject questionnaires) and (ii) efficacy of the robotic rehabilitation for improving functional outcomes (Graded and Redefined Assessment of Strength, Sensibility and Prehension (GRASSP), action research arm test, grip dynamometry and range of motion). By the end of the training period, the robot-assisted training was shown to require active therapist involvement for 25 +/- 11 % (mean +/- S.D.) of the total session time. In the group of all subjects and in a subgroup composed of motor-incomplete subjects, no statistically significant differences were found between intervention and control limbs for any of the outcome measures. In a subgroup of subjects with partial hand function at baseline, the GRASSP-Sensibility component showed a statistically significant increase (6.0 +/- 1.6 (mean +/- S.E.M.) point increase between baseline and discharge for the intervention limbs versus 1.9 +/- 0.9 points for the control limbs). The authors concluded that these findings suggested that individuals with some preserved hand function after SCI may be better candidates for rehabilitation training using the Armeo Spring device.
Schwartz et al (2011) evaluated the effect of an additive RAGT using the Lokomat system on the neurological and functional outcomes of patients with subacute SCI. A total of 28 subacute SCI patients were treated by RAGT, 2 to 3 times a week, 30 to 45 mins every treatment, concomitantly with regular physiotherapy. As control, for each patient, these investigators matched a comparable patient treated in the same department in previous years, according to age, severity of injury, level of injury and cause. The main outcomes were: the AIS (American Spinal Injury Association impairment scale) the spinal cord independence measurement (SCIM) score, the walking index for SCI II (WISCI II) and functional ambulation category scale (FAC). At the end of rehabilitation, both groups showed a significant improvement in both the FAC score and the WISCI score (p < 0.01) without differences between the groups. Functional abilities, according to the SCIM score, were also improved, with a significant interaction effect; the RAGT patients improve by 30 +/- 20 points, which was significantly greater gain as compared with the controls, 21 +/- 14 points (p = 0.05). This improvement was mainly due to the change in the SCIM motor subscales. The authors concluded that RAGT is an important additional treatment to improve the functional outcome of subacute SCI patients. They stated that larger, controlled studies are still needed to determine the optimal timing and protocol design for the maximal efficacy of RAGT in SCI patients.
In an open-label pilot study, Stein et al (2011) tested a new robotic device for hand rehabilitation in stroke survivors. A total of 12 individuals with chronic moderate hemiparesis after stroke were enrolled in this study. Participants underwent a 6-week training program using a hand robotic device. They received a total of 18 hrs of robotic therapy. Improvements were found in multiple measures of motor performance, including the Upper Extremity Fugl-Meyer test, the Motor Activity Log, the Manual Ability Measure-36, and the Jebsen Hand Function Test. All subjects tolerated the treatment well and no complications were observed. The authors concluded that robotic therapy for hand paresis after stroke is safe and feasible, and further studies of efficacy are justified by these preliminary results.
Norouzi-Gheidari et al (2012) systematically reviewed and analyzed the literature to find RCTs that employed robotic devices in upper-limb rehabilitation of people with stroke. Out of 574 studies, 12 matching the selection criteria were found. The Fugl-Meyer, Functional Independence Measure, Motor Power Scale, and Motor Status Scale outcome measures from the selected RCTs were pooled together, and the corresponding effect sizes were estimated. These researcehrs found that when the duration/intensity of conventional therapy (CT) was matched with that of the robot-assisted therapy (RT), no difference exists between the intensive CT and RT groups in terms of motor recovery, ADL, strength, and motor control. However, depending on the stage of recovery, extra sessions of RT in addition to regular CT are more beneficial than regular CT alone in motor recovery of the hemiparetic shoulder and elbow of patients with stroke; gains are similar to those that have been observed in intensive CT.
In a Cochrane review, Mehrholz et al (2012) evaluated the effectiveness of electromechanical and robot-assisted arm training for improving generic ADL, arm function, and arm muscle strength in patients after stroke. These investigators also assessed the acceptability and safety of the therapy. They searched the Cochrane Stroke Group's Trials Register (last searched July 2011), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 7), MEDLINE (1950 to July 2011), EMBASE (1980 to July 2011), CINAHL (1982 to July 2011), AMED (1985 to July 2011), SPORTDiscus (1949 to July 2011), PEDro (searched August 2011), COMPENDEX (1972 to July 2011), and INSPEC (1969 to July 2011). They also hand-searched relevant conference proceedings, searched trials and research registers, checked reference lists, and contacted trialists, experts and researchers in the field, as well as manufacturers of commercial devices. Randomized controlled trials comparing electromechanical and robot-assisted arm training for recovery of arm function with other rehabilitation or placebo interventions, or no treatment, for patients after stroke were selected for analysis. Two review authors independently selected trials for inclusion, assessed trial quality, and extracted data. They contacted trialists for additional information. They analysed the results as standardized mean differences (SMDs) for continuous variables and risk differences (RDs) for dichotomous variables. These researchers included 19 trials (involving 666 participants) in this updated review. Electromechanical and robot-assisted arm training did improve activities of daily living (SMD 0.43, 95 % confidence interval (CI): 0.11 to 0.75, p = 0.009, I(2) = 67 %) as well as arm function (SMD 0.45, 9 5% CI: 0.20 to 0.69, p = 0.0004, I(2) = 45 %), but arm muscle strength did not improve (SMD 0.48, 95 % CI: -0.06 to 1.03, p = 0.08, I(2) = 79 %). Electromechanical and robot-assisted arm training did not increase the risk of patients to drop-out (RD 0.00, 95 % CI: -0.04 to 0.04, p = 0.82, I(2) = 0.0 %), and adverse events were rare. The authors concluded that patients who receive electromechanical and robot-assisted arm training after stroke are more likely to improve their generic ADL. Paretic arm function may also improve, but not arm muscle strength. However, the authors stated that results must be interpreted with caution because there were variations between the trials in the duration and amount of training, type of treatment, and in the patient characteristics.
Hussain et al (2011) stated that the rehabilitation engineering community is working towards the development of robotic devices that can assist during gait training of patients suffering from neurologic injuries such as stroke and SCI. The field of robot-assisted treadmill training has rapidly evolved during the last decade. The robotic devices can provide repetitive, systematic and prolonged gait training sessions. These researchers presented a review of the treadmill-based robotic gait training devices. An overview of design configurations and actuation methods used for these devices was provided. Training strategies designed to actively involve the patient in robot-assisted treadmill training were studied. These training strategies assist the patient according to the level of disability and type of neurologic injury. The authors stated that although the effectiveness of these training strategies is not clinically proven, adaptive strategies may result in substantial improvements.
Alcobendas-Maestro et al (2012) compared a walking re-education program using Lokomat with conventional over-ground training among individuals with incomplete SCI of both traumatic and non-traumatic etiology. A total of 80 participants from 3 to 6 months after onset admitted to 1 site for rehabilitation were included in a single-blind RCT of 2 parallel groups, with blind evaluation by independent observers. Patients received 40 walking re-education sessions of equal time using a Lokomat program with over-ground practice or over-ground mobility therapy alone. Primary measurements of outcome were walking speed and the WISCI II; secondary outcomes were the 6-min walk test, locomotor section of the functional independence measure, lower extremity motor score (LEMS), Ashworth Scale, and visual analog scale for pain. No significant differences were found at entry between treatment groups. Walking speed for Lokomat (0.4 m/s [0.6 to 0.2]) and over-ground therapy (0.3 m/s [0.5 to 0.2]) groups did not differ. The WISCI II for the Lokomat group (16 [8.5 to 19]) was better than for over-ground therapy (9 [8 to 16]). The 6-min walk test and LEMS displayed significant differences in favor of Lokomat therapy but were not corrected for multiple comparisons. The authors concluded that robotic-assisted training was equivalent to conventional walk training in patients with a variety of non-progressive spinal cord pathologies for walking speed, but the need for orthotics and assistive devices was reduced, perhaps because of greater leg strength in the robotic group.
In a Cochrane review, Mehrholz et al (2013) examined the effects of automated electromechanical and robotic-assisted gait training devices for improving walking after stroke. These investigators searched the Cochrane Stroke Group Trials Register (last searched April 2012), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 2), MEDLINE (1966 to November 2012), EMBASE (1980 to November 2012), CINAHL (1982 to November 2012), AMED (1985 to November 2012), SPORTDiscus (1949 to September 2012), the Physiotherapy Evidence Database (PEDro, searched November 2012) and the engineering databases COMPENDEX (1972 to November 2012) and INSPEC (1969 to November 2012). They also hand-searched relevant conference proceedings, searched trials and research registers, checked reference lists and contacted authors in an effort to identify further published, unpublished and ongoing trials. These researchers included all randomized and randomized cross-over trials consisting of people over 18 years old diagnosed with stroke of any severity, at any stage, or in any setting, evaluating electromechanical and robotic-assisted gait training versus normal care. Two review authors independently selected trials for inclusion, assessed methodological quality and extracted the data. The primary outcome was the proportion of participants walking independently at follow-up. In this update of their review, these investigators included 23 trials involving 999 participants. Electromechanical-assisted gait training in combination with physiotherapy increased the odds of participants becoming independent in walking (odds ratio (OR) (random effects) 2.39, 95 % CI: 1.67 to 3.43; p < 0.00001; I² = 0 %) but did not significantly increase walking velocity (mean difference (MD) = 0.04 meters/s, 95% CI: -0.03 to 0.11; p = 0.26; I² = 73 %) or walking capacity (MD = 3 meters walked in 6 minutes, 95 % CI: -29 to 35; p = 0.86; I² = 70 %). The results must be interpreted with caution because (i) some trials investigated people who were independent in walking at the start of the study, (ii) these researchers found variations between the trials with respect to devices used and duration and frequency of treatment, and (iii) some trials included devices with functional electrical stimulation. The planned subgroup analysis suggested that people in the acute phase may benefit but people in the chronic phase may not benefit from electromechanical-assisted gait training. Post-hoc analysis showed that people who are non-ambulatory at intervention onset may benefit but ambulatory people may not benefit from this type of training. Furthermore, post-hoc analysis showed no differences between the types of devices used in studies regarding ability to walk, but significant differences were found between devices in terms of walking velocity. The authors concluded that people who receive electromechanical-assisted gait training in combination with physiotherapy after stroke are more likely to achieve independent walking than people who receive gait training without these devices. Specifically, people in the first 3 months after stroke and those who are not able to walk seem to benefit most from this type of intervention. The role of the type of device is still not clear. They stated that further research should consist of a large definitive, pragmatic, phase III trial undertaken to address specific questions such as the following: What frequency or duration of electromechanical-assisted gait training might be most effective? How long does the benefit last?
Morawietz and Moffat (2013) provided an overview of, and evaluated the current evidence on, locomotor training approaches for gait rehabilitation in individuals with incomplete SCI to identify the most effective therapies. The following electronic databases were searched systematically from first date of publication until May 2013: Allied and Complementary Medicine Database, Cumulative Index to Nursing and Allied Health Literature, Cochrane Database of Systematic Reviews, Medline, Physiotherapy Evidence Database, and PubMed. References of relevant clinical trials and systematic reviews were also hand-searched. Only RCTs evaluating locomotor therapies after incomplete SCI in an adult population were included. Full-text versions of all relevant articles were selected and evaluated by both authors. Eligible studies were identified, and methodological quality was assessed with the Physiotherapy Evidence Database scale. Articles scoring less than 4 points on the scale were excluded. Sample population, interventions, outcome measures, and findings were evaluated with regard to walking capacity, velocity, duration, and quality of gait. Data were analyzed by systematic comparison of findings. A total of 8 articles were included in this review; 5 compared body-weight-supported treadmill training (BWSTT) or robotic-assisted BWSTT with conventional gait training in acute/subacute subjects (less than or equal to 1 year post-injury). The remaining studies each compared 3 or 4 different locomotor interventions in chronic participants (greater than1y post-injury). Sample sizes were small, and study designs differed considerably impeding comparison. Only minor differences in outcomes measures were found between groups. Gait parameters improved slightly more after BWSTT and robotic gait training for acute participants. For chronic participants, improvements were greater after BWSTT with functional electrical stimulation (FES) and over-ground training with FES/body-weight support compared with BWSTT with manual assistance, robotic gait training, or conventional physiotherapy. The authors concluded that evidence on the effectiveness of locomotor therapy is limited. All approaches show some potential for improvement of ambulatory function without superiority of 1 approach over another. They stated that more research on this topic is required.
Dobkin and Duncan (2012) stated that body weight-supported treadmill training (BWSTT) and robotic-assisted step training (RAST) have not, so far, led to better outcomes than a comparable dose of progressive over-ground training (OGT) for disabled persons with stroke, SCI, multiple sclerosis (MS), Parkinson's disease (PD), or CP. The conceptual bases for these promising rehabilitation interventions had once seemed quite plausible, but the results of well-designed, RCTs have been disappointing. The authors re-assessed the under-pinning concepts for BWSTT and RAST, which were derived from mammalian studies of treadmill-induced hind-limb stepping associated with central pattern generation after low thoracic spinal cord transection, as well as human studies of the triple-crown icons of task-oriented locomotor training, massed practice, and activity-induced neuroplasticity. The authors retrospectively considered where theory and practice may have fallen short in the pilot studies that aimed to produce thoroughbred interventions. Based on these shortcomings, the authors moved forward with recommendations for the future development of workhorse interventions for walking. The authors concluded that in the absence of evidence for physical therapists to employ these strategies, however, BWSTT and RAST should not be provided routinely to disabled, vulnerable persons in place of OGT outside of a scientifically conducted efficacy trial.
Vaney et al (2012) examined if RAGT (Lokomat) is superior to over-ground walking training in terms of quality of life, activity level, and gait in patients with MS. A total of 67 patients with MS with the Expanded Disability Status Scale (EDSS) 3.0 to 6.5 were randomized to walking or RAGT, in addition to multi-modal rehabilitation. Primary outcomes were walking speed, activity level (estimated metabolic equivalent, metabolic equivalents [METs], using an accelerometer), and quality of life (Well-Being visual analog scale (VAS) and EQ-5D European VAS. In all, 49 patients finished the interventions. Mean age was 56 years (range of 36 to 74 years), mean EDSS was 5.8 (3.0 to 6.5), and the preferred walking speed at baseline was 0.56 m/s (0.06 to 1.43 m/s). Before rehabilitation, participants spent on average 68 min/day at an MET greater than or equal to 3. The walking group improved gait speed non-significantly more than the RAGT; the upper bound of the CI did not exclude a clinically relevant benefit (defined as a difference of 0.05 m/s) in favor of the walking group; the lower bound of the CI did exclude a clinically important benefit in favor of the Lokomat. Quality of life improved in both groups, with a non-significant between-group difference in favor of the walking group. Both groups had reduced their activity by 8 weeks after the rehabilitation. The authors concluded that it is unlikely that RAGT is better than over-ground walking training in patients with an EDSS between 3.0 and 6.5.
In a RCT, Picelli et al (2012) examined if a rehabilitation program of RAGT is more effective than conventional physiotherapy to improve walking in patients with PD. A total of 41 patients with PD were randomly assigned to 45-min treatment sessions (12 in all), 3 days a week, for 4 consecutive weeks of either robotic stepper training (RST; n = 21) using the Gait Trainer or physiotherapy (PT; n = 20) with active joint mobilization and a modest amount of conventional gait training. Participants were evaluated before, immediately after, and 1 month after treatment. Primary outcomes were 10-m walking speed and distance walked in 6 mins. Baseline measures revealed no statistical differences between groups, but the PT group walked 0.12 m/s slower; 5 patients withdrew. A statistically significant improvement was found in favor of the RST group (walking speed 1.22 ± 0.19 m/s [p = 0.035]; distance 366.06 ± 78.54 m [p < 0.001]) compared with the PT group (0.98 ± 0.32 m/s; 280.11 ± 106.61 m). The RAGT mean speed increased by 0.13 m/s, which is probably not clinically important. Improvements were maintained 1 month later. The authors concluded that RAGT may improve aspects of walking ability in patients with PD. Moreover, they stated that future trials should compare robotic assistive training with treadmill or equal amounts of over-ground walking practice.
Yang and colleagues (2014) evaluated the plantar pressure distribution during the robotic-assisted walking, guided through normal symmetrical hip and knee physiological kinematic trajectories, with unassisted walking in post-stroke hemiplegic patients. A total of 15 hemiplegic stroke patients (who were able to walk a minimum of 10 meters independently but with asymmetric gait patterns) were enrolled in this study. All the patients performed both the robotic-assisted walking (Lokomat) and the unassisted walking on the treadmill with the same body support in random order. The contact area, contact pressure, trajectory length of center of pressure (COP), temporal data on both limbs and asymmetric index of both limbs were obtained during both walking conditions, using the F-Scan in-shoe pressure measurement system. The contact areas of mid-foot and total foot on the affected side were significantly increased in robotic-assisted walking as compared to unassisted walking (p < 0.01). The contact pressures of mid-foot and total foot on affected limbs were also significantly increased in robotic-assisted walking (p < 0.05). The antero-posterior and medio-lateral trajectory length of COP were not significantly different between the 2 walking conditions, but their trajectory variability of COP was significantly improved (p < 0.05). The asymmetric index of area, stance time, and swing time during robotic-assisted walking were statistically improved as compared with unassisted walking (p < 0.05). The authors concluded that the robotic-assisted walking may be helpful in improving the gait stability and symmetry, but not the physiologic ankle rocker function.
In a randomized controlled trial, Gandolfi and associates (2014) compared the effectiveness of end-effector RAGT and sensory integration balance training (SIBT) in improving walking and balance performance in patients with MS. A total of 22 patients with MS (EDSS: 1.5 to 6.5) were randomly assigned to 2 groups. The RAGT group (n = 12) underwent end-effector system training; the SIBT group (n = 10) underwent specific balance exercises. Each patient received 12 50-min treatment sessions (2 days/week). A blinded rater evaluated patients before and after treatment as well as 1 month post-treatment. Primary outcomes were walking speed and Berg Balance Scale. Secondary outcomes were the Activities-specific Balance Confidence Scale, Sensory Organization Balance Test, Stabilometric Assessment, Fatigue Severity Scale, cadence, step-length, single and double support time, Multiple Sclerosis Quality of Life-54. Between groups comparisons showed no significant differences on primary and secondary outcome measures over time. Within group comparisons showed significant improvements in both groups on the Berg Balance Scale (p = 0.001). Changes approaching significance were found on gait speed (p = 0.07) only in the RAGT group. Significant changes in balance task-related domains during standing and walking conditions were found in the SIBT group. The authors concluded that balance disorders in patients with MS may be ameliorated by RAGT and by SIBT.
In a randomized controlled trial, Picelli and colleagues (2014) compared RAGT versus balance training for reducing postural instability in patients with PD. The secondary aim was to compare their effects on the level of confidence during activities of daily living requiring balance, functional mobility and severity of disease. A total of 66 patients with PD at Hoehn and Yahr Stage 3 were enrolled in this study. After balanced randomization, all patients received 12, 45-min treatment sessions, 3 days a week, for 4 consecutive weeks. A group underwent RAGT with progressive gait speed increasing and body-weight support decreasing. The other group underwent balance training aimed at improving postural reactions (self and externally induced destabilization, coordination, loco-motor dexterity exercises). Patients were evaluated before, after and 1 month post-treatment. Main outcome measure was Berg Balance Scale; secondary outcomes included Activities-Specific Balance Confidence Scale; Timed Up and Go Test; Unified Parkinson's Disease Rating Scale. No significant differences were found between the groups for the Berg Balance Scale either immediately after intervention (mean score in the RAGT group 51.58 ± 3.94; mean score in the balance training group 51.15 ± 3.46), or 1-month follow-up (mean score in the robotic training group 51.03 ± 4.63; mean score in the balance training group 50.97 ± 4.28). Similar results were found for all the secondary outcome measures. The authors concluded that these findings indicated that RAGT is not superior to balance training for improving postural instability in patients with mild-to-moderate PD.
|CPT Codes / HCPCS Codes / ICD-9 Codes|
|There are no specific codes for Robotic-assisted Rehabilitation:|
|ICD-9 codes not covered for indications listed in the CPB (not all-inclusive)::|
|332.0 - 332.1||Parkinson disease|
|343.0 - 343.9||Cerebral palsy|
|358.00 - 358.9||Myoneural disorders|
|438.20 - 438.53||Late effects of cerebrovascular disease, hemiplegia/hemiparesis, monoplegia of upper or lower limb, or other paralytic syndrome|
|438.89 - 438.9||Other and unspecified late effects of cerebrovascular disease|
|952.04, 952.09, 952.14, 952.19 – 952.9||Spinal cord injury [incomplete spinal cord lesion]|
|CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for clarification purposes.  Codes requiring a 7th character are represented by "+":|
|ICD-10 codes will become effective as of October 1, 2015:|
|There are no specific codes for Robotic-assisted Rehabilitation:|
|ICD-10 codes not covered for indications listed in the CPB (not all-inclusive)::|
|G20 - G21.9||Parkinson's disease|
|G70.00 - G70.9
G73.1 - G73.3
|Myasthenia gravis and other myoneural disorders|
|G80.0 - G80.2
G80.4 - G80.9
|I69.031 - I69.069
I69.131 - I69.169
I69.231 - I69.269
I69.331 - I69.369
I69.831 - I69.869
I69.931 - I69.969
|Sequelae of cerebrovascular disease, monoplegia, hemiplegia and hemiparesis, and other paralytic syndrome|
|I69.090 - I69.098
I69.190 - I69.198
I69.290 - I69.298
I69.390 - I69.398
I69.890 - I69.898
I69.990 - I69.998
|Other sequelae of cerebrovascular disease|
|I69.093, I69.193, I69.293
I69.393, I69.893, I69.993
|Sequelae of cerebrovascular disease, ataxia|
|S14.151+ - S14.159+S24.151+ - S24.159+S34.121+ - S34.129+S34.132||Incomplete lesion of spinal cord|